methazolamide has been researched along with Benign Intracranial Hypertension in 1 studies
Methazolamide: A carbonic anhydrase inhibitor that is used as a diuretic and in the treatment of glaucoma.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A robust predictor of visual outcome in idiopathic intracranial hypertension (IIH) would be useful in management, but there is limited information on this point." | 1.51 | Visual Field Mean Deviation at Diagnosis of Idiopathic Intracranial Hypertension Predicts Visual Outcome. ( Cornblath, WT; De Lott, L; Mikkilineni, S; Trobe, JD, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mikkilineni, S | 1 |
| Trobe, JD | 1 |
| Cornblath, WT | 1 |
| De Lott, L | 1 |
1 other study available for methazolamide and Benign Intracranial Hypertension
| Article | Year |
|---|---|
Visual Field Mean Deviation at Diagnosis of Idiopathic Intracranial Hypertension Predicts Visual Outcome.
Topics: Acetazolamide; Adolescent; Adult; Carbonic Anhydrase Inhibitors; Diuretics; Drug Therapy, Combinatio | 2019 |